Renal cell cancer is one of the tenth most frequent tumor-dependent causes of death worldwide. In localized stages surgical therapy is the only curative option for the patient. If a renal cell carcinoma is diagnosed in late, i.e. advanced/metastasized stages a drug therapy with targeted agents following tumor burden surgery is nowadays the best option to increase patients progression-free survival. Whenever possible, a partial resection should be perform on regard to decrease rates of longtime renal failure.
|Translated title of the contribution||Renal cell cancer. From symptoms to therapy|
|Number of pages||7|
|Publication status||Published - 02.2013|
Research Areas and Centers
- Research Area: Luebeck Integrated Oncology Network (LION)